NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biolinco

Biolinco

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://biolinco.com/

Last Round

Accelerator

Mar 9, 2026

Total Funding Raised

$232,500

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Biolinco is a healthcare technology company that provides a biopharmaceutical therapies platform designed to reduce the cost of biomanufacturing by increasing drug yields.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

cell line developmentCLDhigh-throughput screeningDNA barcodingcontract development and manufacturing organizationCDMObiologics manufacturingbiopharmaceutical platformCHO cell line developmentcell line engineeringdrug yield optimizationcell clone selectionmaster cell bank generationmonoclonal antibody developmentbiosimilar development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biolinco Comps

Public and private peers based on sector, stage, and business model.

Biolinco comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biolinco Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 9, 2026
GrantJun 4, 2024

Biolinco Investors

Notable investors and investment history

Biolinco investors
InvestorRounds
TechstarsAccelerator
Johns Hopkins University EndowmentAccelerator, Grant
HopStone CapitalAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors grew 108% MoM.

Biolinco Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biolinco Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biolinco's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range2
Year Founded2023
Last FundingMar 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.